Gan HK - Search Results

1

The EGFRvIII variant in glioblastoma multiforme.

Gan HK, Kaye AH, Luwor RB. Gan HK, et al. J Clin Neurosci. 2009 Jun;16(6):748-54. doi: 10.1016/j.jocn.2008.12.005. Epub 2009 Mar 25. J Clin Neurosci. 2009. PMID: 19324552 Review.

2

Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity.

Perera RM, Narita Y, Furnari FB, Gan HK, Murone C, Ahlkvist M, Luwor RB, Burgess AW, Stockert E, Jungbluth AA, Old LJ, Cavenee WK, Scott AM, Johns TG. Perera RM, et al. Among authors: gan hk. Clin Cancer Res. 2005 Sep 1;11(17):6390-9. doi: 10.1158/1078-0432.CCR-04-2653. Clin Cancer Res. 2005. PMID: 16144944

3

Management of glioblastoma in Victoria, Australia (2006-2008).

Gan HK, Rosenthal MA, Cher L, Dally M, Drummond K, Murphy M, Thursfield V. Gan HK, et al. J Clin Neurosci. 2015 Sep;22(9):1462-6. doi: 10.1016/j.jocn.2015.03.029. J Clin Neurosci. 2015. PMID: 26117358

4

First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma.

Whittle JR, Lickliter JD, Gan HK, Scott AM, Simes J, Solomon BJ, MacDiarmid JA, Brahmbhatt H, Rosenthal MA. Whittle JR, et al. Among authors: gan hk. J Clin Neurosci. 2015 Dec;22(12):1889-94. doi: 10.1016/j.jocn.2015.06.005. Epub 2015 Aug 13. J Clin Neurosci. 2015. PMID: 26279503 Clinical Trial.

5

Recurrent glioblastoma: Current patterns of care in an Australian population.

Parakh S, Thursfield V, Cher L, Dally M, Drummond K, Murphy M, Rosenthal MA, Gan HK. Parakh S, et al. Among authors: gan hk. J Clin Neurosci. 2016 Feb;24:78-82. doi: 10.1016/j.jocn.2015.08.025. Epub 2015 Nov 6. J Clin Neurosci. 2016. PMID: 26549675

6

EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism.

Gomez J, Areeb Z, Stuart SF, Nguyen HPT, Paradiso L, Zulkifli A, Madan S, Rajagopal V, Montgomery MK, Gan HK, Scott AM, Jones J, Kaye AH, Morokoff AP, Luwor RB. Gomez J, et al. Among authors: gan hk. Cancers (Basel). 2021 Mar 10;13(6):1198. doi: 10.3390/cancers13061198. Cancers (Basel). 2021. PMID: 33801941 Free PMC article.

7

Targeting of a conformationally exposed, tumor-specific epitope of EGFR as a strategy for cancer therapy.

Gan HK, Burgess AW, Clayton AH, Scott AM. Gan HK, et al. Cancer Res. 2012 Jun 15;72(12):2924-30. doi: 10.1158/0008-5472.CAN-11-3898. Epub 2012 Jun 1. Cancer Res. 2012. PMID: 22659454 Review.

8

A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.

Wong SF, Gan HK, Cher L. Wong SF, et al. Among authors: gan hk. J Clin Neurosci. 2012 Nov;19(11):1501-5. doi: 10.1016/j.jocn.2012.04.001. Epub 2012 Sep 17. J Clin Neurosci. 2012. PMID: 22995759

9

The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered.

Gan HK, Cvrljevic AN, Johns TG. Gan HK, et al. FEBS J. 2013 Nov;280(21):5350-70. doi: 10.1111/febs.12393. Epub 2013 Jul 8. FEBS J. 2013. PMID: 23777544 Free article. Review.

10

Low-grade oligodendroglioma: current treatments and future hopes.

Lwin Z, Gan HK, Mason WP. Lwin Z, et al. Among authors: gan hk. Expert Rev Anticancer Ther. 2009 Nov;9(11):1651-61. doi: 10.1586/era.09.127. Expert Rev Anticancer Ther. 2009. PMID: 19895248 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters